AXIM BIOTECHNOLOGIES, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 20.00 million shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2024-03-31 was 20.00M shares, a 464.29% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2023-03-31 was 3.54M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month as first filed |
|---|---|---|---|---|
| 2024-06-30 | 20.00M shares 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | 20.00M shares 10-Q/A · filed 2024-05-22 | |||
| 2023-03-31 | 3.54M shares 10-Q · filed 2023-05-22 | |||
| 2022-12-31 | 20.00M shares 10-Q · filed 2024-05-20 | 3.54M shares 10-K · filed 2023-04-17 |